{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:58:27Z","timestamp":1772956707587,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1053\/j.semnuclmed.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T09:02:32Z","timestamp":1625734952000},"page":"544-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Practical Considerations When Interpreting FDG PET\/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients"],"prefix":"10.1053","volume":"51","author":[{"given":"Christophe","family":"Van de Wiele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gebreurs","family":"Juanito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borght K.","family":"Vander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismaheel","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Sathekge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart","family":"De Spiegeleer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0001","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejcsup.2013.07.012","article-title":"Melanoma epidemiology, biology and prognosis","volume":"11","author":"Larkin","year":"2013","journal-title":"EJC Supplements"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jid.2020.03.943","article-title":"Treatment of advanced melanoma in 2020 and beyond","volume":"14","author":"Jenkins","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103044","article-title":"Rational use of 18F-FDG PET\/CT in patients with advanced cutaneous melanoma: a systematic review","volume":"153","author":"Bisschop","year":"2020","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0004","first-page":"259","article-title":"18F-FDG PET\/CT and melanoma: staging, immune modulation and mutation-targeted therapy assessment, and prognosis","volume":"205","author":"Perng","year":"2015","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0005","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clindermatol.2012.08.004","article-title":"Sentinel lymph node biopsy for melanoma: A critical update for dermatologists after two decades of experience","volume":"31","author":"Ross","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0006","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional lymphatic mappping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0007","first-page":"1491","article-title":"Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma","volume":"41","author":"Crippa","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0008","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1148\/radiol.2493080240","article-title":"Vander Borght T. Role of PET in the initial staging of cutaneous malignant melanoma: Systematic review","volume":"249","author":"Krug","year":"2008","journal-title":"Radiology"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/2046-4053-1-62","article-title":"F-18-fluror-2-deoxyglucose positron emission tomography (PET) and PET\/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review","volume":"1","author":"Schro\u00ebr-G\u00fcnther","year":"2012","journal-title":"Syst Rev"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.suronc.2014.01.002","article-title":"Value of positron emission tomography scan in stage III cutaneous melanoma: A systematic review and meta-analysis","volume":"23","author":"Rodriguez Rivera","year":"2014","journal-title":"Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0011","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00259-009-1224-8","article-title":"Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma","volume":"37","author":"Jimen\u00e9z-Requena","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0012","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000501398","article-title":"Role of 18F-Flurodeoixyglucose positron emission tomography or positron emission tomography\/computed tomography for the detection of recurrent disease after treatment of malignant melanoma","volume":"97","author":"Lee","year":"2019","journal-title":"Oncology"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0013","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cncr.21189","article-title":"Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma","volume":"104","author":"Wagner","year":"2005","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0014","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13139-017-0495-4","article-title":"Evaluation of 18F-FDG PET\/CT parameters for detection of lymph node metastasis in cutaneous melanoma","volume":"52","author":"Cha","year":"2018","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eight edition American Joint Committee on Cancer (AJCC) melanoma staging system. Implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0016","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0017","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/CMR.0000000000000666","article-title":"Staging 18F-FDG PET\/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases","volume":"30","author":"Holtkamp","year":"2020","journal-title":"Melanoma Res"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0018","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s12094-019-02252-2","article-title":"Utility of PET\/CT in patients with stage I-III melanoma","volume":"22","author":"Avil\u00e9s Izquierdo","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0019","article-title":"Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma","volume":"7","author":"Dinnes","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0020","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.1990.01070110084030","article-title":"Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Syudy. COMS report no 1","volume":"108","year":"1990","journal-title":"Arch Ophtalmol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0021","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/1450-1147.167599","article-title":"Poor uptake of fluorodeoxyglucose in positron emission tomography-computed tomography scan for intraocular choroidal melanoma in asian indian eyes","volume":"15","author":"Sharma","year":"2016","journal-title":"World J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0022","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/IAE.0b013e3181b32f36","article-title":"Association of positive dual-modality positron emission tomography\/computed tomography imaging of primary choroidal melanoma with chromosme 3 loss and tumor size","volume":"30","author":"McCannel","year":"2010","journal-title":"Retina"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0023","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/cncr.25634","article-title":"Prognostic factors for survival in melanoma patients with brain metastasis","volume":"117","author":"Davies","year":"2011","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0024","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1536-1632(02)00024-0","article-title":"Cerebral lesions incidentally detected on 2-deoxy-2(18F)fluoro-D-glucose positron emission tomography images of patients evaluated for body malignancies","volume":"4","author":"Ludwig","year":"2002","journal-title":"Mol Imaging Biol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ejca.2006.11.014","article-title":"Prospective comparison of postron emission tomography\/Computed tomography and whole-body magnetic resonance imaging in staging of advanced melanoma","volume":"43","author":"Pfannenberg","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0026","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/1097-0142(20010501)91:9<1814::AID-CNCR1201>3.0.CO;2-W","article-title":"Burden of illness associated with metastatic melanoma: an audit of 100 consecutive referreal center cases","volume":"91","author":"Hillner","year":"2001","journal-title":"Cancer"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0027","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3109\/02841860903440254","article-title":"Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma","volume":"49","author":"Krug","year":"2010","journal-title":"Acta Oncologica"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0028","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00259-005-1901-1","article-title":"PET recognition of pulmonary metastases on PET\/CT imaging: impact of attenuation-corrected and non-atteunation corrected PET images","volume":"33","author":"Reinhardt","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0029","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-012-2499-x","article-title":"Assessment of pulmonary melanoma metastases with 18F-FDG PET\/CT: which PET-negative patients require additional tests for definitive staging?","author":"Mayerhoefer","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0030","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1200\/JCO.2008.20.1822","article-title":"Prospective comparison of (18F)fluorodeoxyglucose positron emission tomography and computed tomography in patients with melanoma with palpable lymph node metastases: Diagnostic accuracy and impact on treatment","volume":"27","author":"Bastiaannet","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0031","doi-asserted-by":"crossref","first-page":"e5882","DOI":"10.1097\/MD.0000000000005882","article-title":"Breath-hold and free-breathing F-18-FDG-PET\/CT in malignant melanoma-detection of additional tumoral foci and effects on quantitative parameters","volume":"96","author":"B\u00e4rwolf","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3348\/kjr.2006.7.1.57","article-title":"False positive and false negative FDG-PET scans in various thoracic diseases","volume":"7","author":"Chang","year":"2006","journal-title":"Korean J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0033","first-page":"PA4821","article-title":"False positive PET CT in non-malignant pulmonary lesions","volume":"54","author":"Turar","year":"2019","journal-title":"Eur Resp J."},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0034","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s41824-017-0021-z","article-title":"Ground glass pulmonary nodules: Their significance in oncology patients and the role of computed tomography and 18F-fluorodeoxyglucose positron emission tomography","volume":"2","author":"Evangelista","year":"2018","journal-title":"Eur J Hybrid Imaging"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1590\/s1806-37562017000000298","article-title":"Rapidly growing pulmonary ground-glmass nodule caused by metastatic melanoma lacking uptake on 18F-FDG PET-CT","volume":"44","author":"Dalpiaz","year":"2018","journal-title":"J Bras Pneumol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0036","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1111\/j.1572-0241.1999.01604.x","article-title":"Melanoma in the gastrointestinal tract","volume":"94","author":"Blecker","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0037","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/archsurg.1996.01430210073013","article-title":"Surgical resection for melanoma metastatic to the gastrointestinal tract","volume":"131","author":"Ollila","year":"1996","journal-title":"Arch Surg"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0038","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00000658-198403000-00013","article-title":"Symptomatic malignant lymphoma of the gastrointestinal tract. Operative treatment and survival","volume":"199","author":"Jorge","year":"1984","journal-title":"Ann Surg"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0039","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00595-004-2741-5","article-title":"Gastrointestinal metastases from malignant melanoma: Report of a case","volume":"34","author":"Wysocki","year":"2004","journal-title":"Surg Today"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00008390-200106000-00012","article-title":"FDG-PET in the detection of gastrointestinal metastases in melanoma","volume":"11","author":"Tatlidil","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0041","first-page":"98","article-title":"A patient with metastatic melanoma of the small bowel","volume":"23","author":"Park","year":"2009","journal-title":"Oncology (Williston Park)"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0042","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.gie.2010.11.028","article-title":"Capsule endoscopy versus positron emission tomography for the detection of small-bowel metastatic melanoma: A pilot study","volume":"73","author":"Prakoso","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0043","first-page":"219","article-title":"Small bowel metastases from melanoma: Does videocapsule provide additional information after FDG positron emission tomography?","volume":"75","author":"Aerts","year":"2012","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0044","first-page":"694","article-title":"Capsule endoscopy for management of small bowel melanoma; Is it time yet?","volume":"8","author":"Prakoso","year":"2012","journal-title":"Gastroenterol Hepatol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0045","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijscr.2013.08.005","article-title":"Solitary metastatic gallbladder malignant melanoma originated from the nasal cavity: A case report","volume":"4","author":"Furumoto","year":"2013","journal-title":"Int J Surg Case Rep"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0046","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/01.rlu.0000246860.97977.e1","article-title":"Gallbladder metastasis from malignant melanoma: Diagnosis with FDG PET\/CT","volume":"31","author":"Rehani","year":"2006","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0047","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/RLU.0000000000002413","article-title":"Gallbladder metastasis from conjunctival melanoma","volume":"44","author":"Cassou-Mounat","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0048","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3413\/Nukmed-0864-16-11","article-title":"18F-FDG PET\/CT in the detection of asymptomatic malignant melanoma recurrence","volume":"56","author":"Lawal","year":"2017","journal-title":"Nuklearmedizin"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0049","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0284185120925481","article-title":"Imaging of colorectal cancer liver metastases using contrast-enhanced US, multidetector CT, MRI and FG PET\/CT: A meta-analysis","volume":"62","author":"Tsili","year":"2021","journal-title":"Acta Radiol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ejrad.2004.07.005","article-title":"Detectability of liver metastases in malignant melanoma: Prospective comparison of magnetic resonance imaging and positron emission tomography","volume":"54","author":"Ghanem","year":"2005","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0051","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1007\/s00259-009-1175-0","article-title":"Limited value of 18F-FDG PET\/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma","volume":"36","author":"Strobel","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0052","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1346-8138.2005.tb00903.x","article-title":"Factors influencing (F-18)2-fluror-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: The role of proliferation rate, viability, glucose transporter expression and hexokinase activity","volume":"32","author":"Yamada","year":"2005","journal-title":"J Dermatol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0053","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1346-8138.2005.tb00904.x","article-title":"Factors influencing (F-18)2-fluror-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: Is FDG a substrate of multidrug resistance (MDR)?","volume":"32","author":"Yamada","year":"2005","journal-title":"J Dermatol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0054","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2214\/ajr.168.2.9016246","article-title":"MR imaging of skeletal metastases","volume":"168","author":"William","year":"1997","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0055","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1212\/WNL.9.11.757","article-title":"Incidence and type of pathologic alterations observed in muscle in routine autopsy surgery","volume":"9","author":"Pearson","year":"1959","journal-title":"Neurology"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0056","first-page":"137","article-title":"Malignant melanoma: Patterns of metastases","volume":"30","author":"Lee","year":"1980","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0057","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1200\/JCO.1983.1.2.126","article-title":"A multifactorial analysis of melanoma IV. Prognostic factors in 200 melanoma patients with distant metastases","volume":"1","author":"Balch","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0058","first-page":"687","article-title":"Clinical presentation, natural history and prognostic factors in advanced melanoma","volume":"149","author":"Amer","year":"1979","journal-title":"Surg Gynecol Obstet"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0059","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/MNM.0000000000000368","article-title":"Multiple and solitary skeletal muscle metastases on 18F-FDG PET\/CT imaging","volume":"36","author":"Nocuri","year":"2015","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0060","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2214\/ajr.137.1.103","article-title":"Skeletal metastases of melanoma: Radiographic, scintigraphic and clinical review","volume":"137","author":"Fon","year":"1981","journal-title":"Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0061","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ejrad.2016.01.012","article-title":"CT imaging of bone and bone marrow infiltration in malignant melanoma- Challenges and limitation of clinical staging in comparison to 18FDG-PET\/CT","volume":"85","author":"Bier","year":"2016","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0062","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejrad.2009.10.031","article-title":"\"One-stop-shop\" staging: Should we prefer FDG-PET\/CT or MRI for the detection of bone metastases","volume":"78","author":"Heusner","year":"2011","journal-title":"Eur J Radiol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0063","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-0038-1625186","article-title":"Malignant melanoma and (18)F-FDG-PET: Should the whole body scan include the legs?","volume":"42","author":"L\u00f6ffler","year":"2003","journal-title":"Nuklearmedizin"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0064","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/RLU.0b013e3182a77cae","article-title":"Comparison of whole-body versus limited whole-body 18F-FDG PET\/CT scan in malignant cutaneous melanoma","volume":"38","author":"Lazaga","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0065","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/MNM.0000000000000747","article-title":"Clinical relevance of 18F-FDG PET\/CT lower-limb imaging in patients with malignant cutaneous melanoma","volume":"38","author":"Plouznikoff","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0066","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1245\/s10434-009-0843-4","article-title":"Verification of musculoskeletal FDG PET-CT findings performed for melanoma staging","volume":"17","author":"Mansour","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0067","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11912-018-0675-0","article-title":"Mucosal melanoma: A literature review","volume":"20","author":"Yde","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0068","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2019.09.013","article-title":"The mutational landscape of mucosal melanoma","volume":"61","author":"Nassar","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0069","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2484\/rcr.v3i1.118","article-title":"Sinonasal malignant melanoma with diffuse carcinomatosis: Initial PET\/CT staging and follow-up CT\/MR imaging","volume":"3","author":"Nguyen","year":"2015","journal-title":"Radiol Case Rep"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0070","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4103\/ijnm.IJNM_25_20","article-title":"A rare case of sinonasal malignant melanoma - Local, regional, and distant spread accurately detected by 18F Fluorodeoxyglucose positron emission tomography\/computed tomography","volume":"35","author":"Parida","year":"2020","journal-title":"Indian J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0071","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1017\/S0022215110002872","article-title":"Melanoma of the middle ear: initial presentation, Fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography imaging and follow up","volume":"125","author":"Huellner","year":"2011","journal-title":"J Laryngol Otol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0072","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00405-011-1664-1","article-title":"The value of 18F-FDG-PET\/CT imaging for sinonasal malignant melanoma","volume":"269","author":"Haerle","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0073","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005537-200202000-00032","article-title":"FDG PET for mucosal malignant melanoma of the head and neck","volume":"112","author":"Goerres","year":"2002","journal-title":"Laryngoscope"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0074","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4103\/1450-1147.207274","article-title":"Positron emission tomography in mucosal melanomas of head and neck: Results from a South Asian Tertiary Cancer Care Center","volume":"16","author":"Agrawal","year":"2017","journal-title":"World J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0075","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/j.semnuclmed.2020.06.001","article-title":"FDG PET\/CT for assessment of immune therapy: Opportunities and understanding pitfalls","volume":"50","author":"Cho","year":"2020","journal-title":"Sem Nucl med"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0076","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00259-020-04967-9","article-title":"The value of 18F-FDG PET\/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: A systematic review and meta-analysis","volume":"48","author":"Ayati","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0077","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1002\/emp2.12209","article-title":"Diagnosis and management of immune-related adverse effects of immune checkpoint therapy in the emergency department","volume":"1","author":"Yeung","year":"2020","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0078","doi-asserted-by":"crossref","first-page":"W992","DOI":"10.2214\/AJR.10.6198","article-title":"Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy","volume":"197","author":"Bronstein","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1053\/j.semnuclmed.2021.06.010_bib0079","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1158\/2326-6066.CIR-15-0102","article-title":"Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with Ipilimumab","volume":"3","author":"Tirumani","year":"2015","journal-title":"Cancer Immunol Res"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821000428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299821000428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:38:17Z","timestamp":1757543897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299821000428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0001299821000428"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.06.010","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical Considerations When Interpreting FDG PET\/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}